Stay updated on MEDI8897 Efficacy in Infant RSV Prevention Clinical Trial
Sign up to get notified when there's something new on the MEDI8897 Efficacy in Infant RSV Prevention Clinical Trial page.

Latest updates to the MEDI8897 Efficacy in Infant RSV Prevention Clinical Trial page
- Check2 days agoChange DetectedAdded Revision: v3.4.3; removed Revision: v3.4.2.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedAdded Revision: v3.4.2. Removed the government-funding operating-status notice and the prior Revision: v3.4.1; these are administrative updates rather than changes to trial content.SummaryDifference0.1%

- Check37 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check45 days agoChange DetectedShow glossary has been added. The wording/capitalization around QC criteria and No FEAR Act data was updated, and the revision label changed to v3.4.0 (from v3.3.4).SummaryDifference0.1%

- Check59 days agoChange DetectedAdded Jarvenpaa, Finland, 04400 to the locations and updated the page revision to v3.3.4; removed Järvenpää, Finland, 04400 and the prior revision v3.3.3.SummaryDifference0.0%

- Check80 days agoChange DetectedAdded a unified 'Locations' section listing all locations (US states and Canadian provinces). Removed the previous per-state 'X Locations' subsections and updated the revision to v3.3.3.SummaryDifference1%

Stay in the know with updates to MEDI8897 Efficacy in Infant RSV Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI8897 Efficacy in Infant RSV Prevention Clinical Trial page.